Dr. Mark Fishman of the Novartis Institutes for Biomedical Research, discusses several current programs in drug discovery that promise to change the practice of medicine. Each grew from basic science discoveries that were driven by curiosity about the beauty of nature, used strange model organisms, and asked fundamental questions of little presumed relevance to medicine.
